Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3672089rdf:typepubmed:Citationlld:pubmed
pubmed-article:3672089lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C0521378lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C0007561lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C0007732lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C0449297lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C1522609lld:lifeskim
pubmed-article:3672089lifeskim:mentionsumls-concept:C1554112lld:lifeskim
pubmed-article:3672089pubmed:issue40lld:pubmed
pubmed-article:3672089pubmed:dateCreated1987-12-17lld:pubmed
pubmed-article:3672089pubmed:abstractTextThe biliary elimination of ceftriaxone, a cephalosporin derivative, was quantitatively studied in man with the help of high pressure liquid chromatography (HPLC). In 6 healthy volunteers a mean peak concentration of 565 +/- 347 (SEM) micrograms/ml was observed in the aspirated duodenal fluid within the first hour after i.v. administration of 2 g ceftriaxone, and 1.4 +/- 0.5% of the dose was recovered during the 4 hours investigation period. In 10 cholecystectomized patients provided with a T-drain, the biliary concentration peak (1078 +/- 158 micrograms/ml) was reached within 1 hour after administration and the total 24 hours recovery amounted to 9.5 +/- 2.9% of the dose given. In 12 patients undergoing cholecystectomy, serum, and choledochal (CB) and gallbladder bile (GB) were peroperatively collected 1 hour after i.v. administration of 2 g ceftriaxone; the respective concentrations were: 199 +/- 10 (serum), 5259 +/- 1085 (CB), and 4533 +/- 809 (GB) micrograms/ml. These data point to excellent biliary elimination of ceftriaxone compared with the other beta-lactams previously studied, and afford evidence of its high therapeutic potential in biliary tract infections.lld:pubmed
pubmed-article:3672089pubmed:languagefrelld:pubmed
pubmed-article:3672089pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3672089pubmed:citationSubsetIMlld:pubmed
pubmed-article:3672089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3672089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3672089pubmed:statusMEDLINElld:pubmed
pubmed-article:3672089pubmed:monthOctlld:pubmed
pubmed-article:3672089pubmed:issn0036-7672lld:pubmed
pubmed-article:3672089pubmed:authorpubmed-author:AdloffMMlld:pubmed
pubmed-article:3672089pubmed:authorpubmed-author:MonteilHHlld:pubmed
pubmed-article:3672089pubmed:authorpubmed-author:BrogardJ MJMlld:pubmed
pubmed-article:3672089pubmed:authorpubmed-author:SinhGGlld:pubmed
pubmed-article:3672089pubmed:authorpubmed-author:BlickleJ FJFlld:pubmed
pubmed-article:3672089pubmed:authorpubmed-author:JehlFFlld:pubmed
pubmed-article:3672089pubmed:authorpubmed-author:Paris-BockelD...lld:pubmed
pubmed-article:3672089pubmed:issnTypePrintlld:pubmed
pubmed-article:3672089pubmed:day3lld:pubmed
pubmed-article:3672089pubmed:volume117lld:pubmed
pubmed-article:3672089pubmed:ownerNLMlld:pubmed
pubmed-article:3672089pubmed:authorsCompleteYlld:pubmed
pubmed-article:3672089pubmed:pagination1549-59lld:pubmed
pubmed-article:3672089pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:meshHeadingpubmed-meshheading:3672089-...lld:pubmed
pubmed-article:3672089pubmed:year1987lld:pubmed
pubmed-article:3672089pubmed:articleTitle[Ceftriaxone, a cephalosporin with high hepatic elimination. Evaluation of its biliary clearance in man. Therapeutic value].lld:pubmed
pubmed-article:3672089pubmed:affiliationDépartement de médecine interne, Centre hospitalo-universitaire, Strasbourg.lld:pubmed
pubmed-article:3672089pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3672089pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3672089pubmed:publicationTypeEnglish Abstractlld:pubmed